Bafna Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹6.85 crore for the September 2026 quarter.
Bafna Pharmaceuticals (NSE: BAFNAPH-BE) closed at ₹469.95 on 20 Nov 2026. Its market capitalisation is ₹1,112 crore and it trades at 96.5 times earnings.
Incorporated in 1981, Bafna Pharmaceuticals Ltd manufactures finished pharmaceutical formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.